Myosin light chain kinase is responsible for high proliferative ability of breast cancer cells via anti-apoptosis involving p38 pathway

Acta Pharmacologica Sinica

Volumn 31, Issue 6, 2010, Pages 725-732

  Cui, Wen Jing ^a   Liu, Yi ^a   Zhou, Xiao Lei ^a   Wang, Feng Ze ^a   Zhang, Xiao Dong ^a   Ye, Li Hong ^a  

^a NANKAI UNIVERSITY   (China)

Author keywords

Apoptosis; Bcl 2 protein; Breast cancer; Caspases; Cell proliferation; ML 7; Myosin light chain kinase; P38; Survivin

Indexed keywords

1 (5 IODO 1 NAPHTHALENESULFONYL)HEXAHYDRO 1H 1,4 DIAZEPINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 9; DOXORUBICIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSIN LIGHT CHAIN KINASE; PROTEIN BCL 2; PROTEIN C JUN; SURVIVIN; SYNAPTOPHYSIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; METASTASIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BLOTTING, WESTERN; BREAST NEOPLASMS; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; DOXORUBICIN; FEMALE; FLOW CYTOMETRY; HUMANS; MAP KINASE SIGNALING SYSTEM; MYOSIN-LIGHT-CHAIN KINASE; NEOPLASM METASTASIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 77953250415     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2010.56     Document Type: Article

References (31)

1. Connell LE, Helfman DM. Myosin light chain kinase plays a role in the regulation of epithelial cell survival. J Cell Sci 2006; 119: 2269-2281
2. Petrache I, Crow MT, Neuss M, Garcia JG. Central involvement of Rho family GTPases in TNF-alpha-mediated bovine pulmonary endothelial cell apoptosis. Biochem Biophys Res Commun 2003; 306: 244-249
3. Petrache I, Verin AD, Crow MT, Birukova A, Liu F, Garcia JG. Differential effect of MLC kinase in TNF-alpha-induced endothelial cell apoptosis and barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2001; 280: L1168-78.
4. Petrache I, Birukov K, Zaiman AL, Crow MT, Deng H, Wadgaonkar R, et al. Caspase-dependent cleavage of myosin light chain kinase (MLCK) is involved in TNF-alpha-mediated bovine pulmonary endothelial cell apoptosis. FASEB J 2003; 17: 407-416
5. Wadgaonkar R, Linz-McGillem L, Zaiman AL, Garcia JG. Endothelial cell myosin light chain kinase (MLCK) regulates TNFalpha-induced NFkappaB activity. J Cell Biochem 2005; 94: 351-364
6. Gu LZ, Hu WY, Antic N, Mehta R, Turner JR, de Lanerolle P. Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells. Eur J Cancer 2006; 42: 948-957
7. Fazal F, Gu L, Ihnatovych I, Han Y, Hu W, Antic N, et al. Inhibiting myosin light chain kinase induces apoptosis in vitro and in vivo. Mol Cell Biol 2005; 25: 6259-6266
8. Diecke FP, Wen Q, Iserovich P, Li J, Kuang K, Fischbarg J. Regulation of Na-K-2Cl cotransport in cultured bovine corneal endothelial cells. Exp Eye Res 2005; 80: 777-785
9. Korzeniewska-Dyl I. Caspases-structure and function. Pol Merkur Lekarski 2007; 23: 403-407
10. Mehlen P, Puisieux A. Metastasis: a question of life or death. Nat Rev Cancer 2006; 6: 449-458
11. Schultz DR, Harrington WJ Jr. Apoptosis: programmed cell death at a molecular level. Semin Arthritis Rheum 2003; 32: 345-369
12. Maruyama J, Naguro I, Takeda K, Ichijo H. Stress-activated MAP kinase cascades in cellular senescence. Curr Med Chem 2009; 16: 1229-1235
13. Rincon M, Davis RJ. Regulation of the immune response by stressactivated protein kinases. Immunol Rev 2009; 228: 212-224
14. Werlen G, Hausmann B, Naeher D, Palmer E. Signaling life and death in the thymus: timing is everything. Science 2003; 299: 1859-1863
15. Wada T, Penninger JM. Mitogen-activated protein kinases in apoptosis regulation. Oncogene 2004; 23: 2838-2849
16. Dent P, Yacoub A, Fisher PB, Hagan MP, Grant S. MAPK pathways in radiation responses. Oncogene 2003; 22: 5885-5896
17. Hommes DW, Peppelenbosch MP, van Deventer SJ. Mitogen activated protein (MAP) kinase signal transduction pathways and novel antiinflammatory targets. Gut 2003; 52: 144-151
18. You J, Mi D, Zhou X, Qiao L, Zhang H, Zhang X, et al. A positive feedback between activated extracellularly regulated kinase and cyclooxygenase/ lipoxygenase maintains proliferation and migration of breast cancer cells. Endocrinology 2009; 150: 1607-1617
19. Wang FZ, Sha L, Zhang WY, Wu LY, Qiao L, Li N, et al. Involvement of hepatitis B X-interacting protein (HBXIP) in proliferation regulation of cells. Acta Pharmacol Sin 2007; 28: 431-438
20. Qiao L, Zhao TJ, Wang FZ, Shan CL, Ye LH, Zhang XD. NF-kappaB downregulation may be involved the depression of tumor cell proliferation mediated by human mesenchymal stem cells. Acta Pharmacol Sin 2008; 29: 333-340
21. Zhou XL, Qin XR, Zhang XD, Ye LH. Downregulation of Dickkopf-1 is responsible for high proliferation of breast cancer cells via losing control of Wnt/beta-catenin signaling. Acta Pharmacol Sin 2010; 31: 202-210
22. Zhou X, Liu Y, You J, Zhang H, Zhang X, Ye L. Myosin light-chain kinase contributes to the proliferation and migration of breast cancer cells through cross-talk with activated ERK1/2. Cancer Lett 2008; 270: 312-327
23. Beresford MJ, Wilson GD, Makris A. Measuring proliferation in breast cancer: practicalities and applications. Breast Cancer Res 2006; 8: 216.
24. Anand S, Penrhyn-Lowe S, Venkitaraman AR. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 2003; 3: 51-62.
25. Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer 2003; 3: 859-868
26. Hermeking H. The 14-3-3 cancer connection. Nat Rev Cancer 2003; 3: 931-943
27. Ye LH, Wu LY, Guo W, Ma HT, Zhang XD. Screening of a sub-clone of human breast cancer cells with high metastasis potential. Zhonghua Yi Xue Za Zhi 2006; 86: 61-65
28. Zhao Y, Chen X, Cai L, Yang Y, Sui G, Wu J. Angiotensin II suppresses adriamycin-induced apoptosis through activation of phosphatidylinositol 3-kinase/Akt signaling in human breast cancer cells. Acta Biochim Biophys Sin 2008; 40: 304-310
29. Tsuchiya T, Tsuno NH, Asakage M, Yamada J, Yoneyama S, Okaji Y, et al. Apoptosis induction by p38 MAPK inhibitor in human colon cancer cells. Hepatogastroenterology 2008; 55: 930-935
30. Makin G, Dive C. Modulating sensitivity to drug-induced apoptosis: the future for chemotherapy? Breast Cancer Res 2001; 3: 150-153
31. Iyoda K, Sasaki Y, Horimoto M, Toyama T, Yakushijin T, Sakakibara M, et al. Involvement of the p38 mitogen-activated protein kinase cascade in hepatocellular carcinoma. Cancer 2003; 97: 3017-3026